Skip to main content
Erschienen in: Reactions Weekly 1/2017

01.09.2017 | Case report

Antineoplastics

Various toxicities: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Delgado CR, et al. Analysis of treatment with vemurafenib and dabrafenib in patients with metastasic melanoma in a tertiary hospital. European Journal of Hospital Pharmacy - Science and Practice 24 (Suppl. 1): A126 abstr. DI-030, Mar 2017. Available from: URL: http://doi.org/10.1136/ejhpharm-2017-000640.277 [abstract] - Spain Delgado CR, et al. Analysis of treatment with vemurafenib and dabrafenib in patients with metastasic melanoma in a tertiary hospital. European Journal of Hospital Pharmacy - Science and Practice 24 (Suppl. 1): A126 abstr. DI-030, Mar 2017. Available from: URL: http://​doi.​org/​10.​1136/​ejhpharm-2017-000640.​277 [abstract] - Spain
Metadaten
Titel
Antineoplastics
Various toxicities: 3 case reports
Publikationsdatum
01.09.2017
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2017
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-017-35515-z

Weitere Artikel der Ausgabe 1/2017

Reactions Weekly 1/2017 Zur Ausgabe

Case report

Multiple drugs

Case report

Clevidipine

Case report

Ticagrelor

Case report

Erlotinib